None
Quote | Avalon GloboCare Corp. (NASDAQ:AVCO)
Last: | $0.5259 |
---|---|
Change Percent: | -17.89% |
Open: | $0.62 |
Close: | $0.5259 |
High: | $0.6507 |
Low: | $0.5202 |
Volume: | 441,123 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Avalon GloboCare Corp. (NASDAQ:AVCO)
Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s New Focus on Laboratory Services and Biotherapeutics FREEHOLD, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon...
Avalon GloboCare ( NASDAQ: AVCO ) to acquire a 60% interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of $25M, net income in excess of $10M and over 600,000 tests completed since inception. With the move...
Message Board Posts | Avalon GloboCare Corp. (NASDAQ:AVCO)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Avalon GloboCare Corp. Company Name:
AVCO Stock Symbol:
NASDAQ Market:
Company to Begin Trading under New Symbol “ALBT” on November 10, 2022 Symbol Change Better Reflects Avalon’s New Focus on Laboratory Services and Biotherapeutics FREEHOLD, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (“Avalon...
Company to acquire a majority interest in Laboratory Services MSO, LLC, a leading reference laboratory with 2021 unaudited revenue in excess of $25 million, net income in excess of $10 million and over 600,000 tests completed since inception Cash portion to be financed with a ...
Freehold, New Jersey--(Newsfile Corp. - October 19, 2022) - Avalon GloboCare Corp. (NASDAQ: AVCO) , a leading global developer of innovative cell-based technologies and therapeutics, announced today that David Jin, M.D., Ph.D., President and Chief Executive Officer, and Luisa Ingargiola, Ch...